Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dr. Martens Plc (DE:3U2)
FRANKFURT:3U2
Dr. Martens Plc (3U2) Stock Price & Analysis
2 Followers
3U2 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€0.73 - €1.86
Previous Close€0.81
Volume100.00
Average Volume (3M)1.22K
Market Cap
€824.87M
Enterprise Value€1.17B
Total Cash (Recent Filing)£157.50M
Total Debt (Recent Filing)£445.80M
Price to Earnings (P/E)11.4
Beta1.88
Next Earnings
Dec 05, 2024EPS EstimateN/A
Next Dividend Ex-Date
Aug 29, 2024Dividend Yield8.08%
Share Statistics
EPS (TTM)0.07
Shares Outstanding961,972,102
10 Day Avg. Volume0
30 Day Avg. Volume1,220
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)2.56
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€0.89Price Target Upside1.05% Upside
Rating ConsensusHold
Number of Analyst Covering5
Dr. Martens Plc News
PremiumCompany Announcements
Dr. Martens CEO Invests in Share Incentive Plan
PremiumCompany Announcements
Dr. Martens Shareholders Approve All AGM Resolutions
PremiumCompany Announcements
Dr. Martens Stays on Track for FY25 GoalsPremiumCompany Announcements
Dr. Martens Announces Current Voting Rights SharesPremiumCompany Announcements
Dr. Martens Executives Granted Performance SharesPremiumCompany Announcements
Dr. Martens Rewards CFO with Share Award
PremiumCompany Announcements
Dr. Martens Announces Major Shareholder ShiftBulls Say, Bears Say
Bulls Say
Company OutlookThe company reiterated its forward outlook for FY24, signaling confidence in its future performance.
LeadershipDr. Martens enhances its executive team by appointing Ije Nwokorie, a former Senior Director of Apple Retail, as Chief Brand Officer, strengthening the company's brand and retail strategy.
Product StrategyThe Direct-to-Consumer rollout, coupled with pricing and space expansion, is poised to drive retail growth.
Bears Say
Earnings DowngradeDr. Martens reported soft 3Q24 revenue with a cFX revenue decline of 18%, leading to a lowered FY24 guidance.
Market SentimentAnalyst has cut the price target to 110p, reflecting a reduced valuation of the company's stock amidst unfavourably warm weather delaying the boot season and affecting sales.
Operational ChallengesSignificant destocking across US wholesale channel has negatively impacted revenues and brought attention to inventory levels as a concern for future cash conversion.
---
Options Prices
Currently, No data available
---
Ownership Overview
40.54% Insiders
9.93% Mutual Funds
3.94% Other Institutional Investors
45.58% Public Companies and
Individual Investors
3U2 FAQ
What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest stock price was €0.73 and its highest was €1.86 in the past 12 months.
What is Dr. Martens Plc’s market cap?
Currently, no data Available
When is Dr. Martens Plc’s upcoming earnings report date?
Dr. Martens Plc’s upcoming earnings report date is Dec 05, 2024 which is in 135 days.
How were Dr. Martens Plc’s earnings last quarter?
Dr. Martens Plc released its earnings results on May 30, 2024. The company reported €0.06 earnings per share for the quarter, missing the consensus estimate of €0.064 by -€0.004.
Is Dr. Martens Plc overvalued?
According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued.
Does Dr. Martens Plc pay dividends?
Dr. Martens Plc pays a Annually dividend of €0.01 which represents an annual dividend yield of 8.08%. See more information on Dr. Martens Plc dividends here
What is Dr. Martens Plc’s EPS estimate?
Dr. Martens Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Martens Plc have?
Dr. Martens Plc has 962,080,100 shares outstanding.
What happened to Dr. Martens Plc’s price movement after its last earnings report?
Dr. Martens Plc reported an EPS of €0.06 in its last earnings report, missing expectations of €0.064. Following the earnings report the stock price went down -4.762%.
Which hedge fund is a major shareholder of Dr. Martens Plc?
Currently, no hedge funds are holding shares in DE:3U2
---
Dr. Martens Plc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€0.89 (1.05% Upside)
€0.89 (1.05% Upside)
Blogger Sentiment
Bullish
DE:3U2 Sentiment 100%
Sector Average 67%
Sector Average 67%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.22%
12-Months-Change
Fundamentals
Return on Equity
17.92%
Trailing 12-Months
Asset Growth
-4.05%
Trailing 12-Months
Company Description
Dr. Martens Plc
Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories.
---
3U2 Stock 12 Month Forecast
Average Price Target
€0.89
▲(1.05% Upside)
Technical Analysis
Dr. Martens Plc
―
J D Wetherspoon
―
Watkin Jones
―
JD Sports Fashion
―
boohoo group Plc
―
Best Analysts Covering 3U2
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
-13.56%
reiterated a sell rating 2 months ago
Copying Louise Singlehurst's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -13.56% per trade.
---